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Background: Peripheral serotonin is involved in tumorigenesis and induces a pro-proliferative effect in
hepatocellular carcinoma (HCC) cells; however, the intracellular mechanisms by which serotonin exerts a mitogenic
effect remain unclear. In this research, we examined whether FOXO3a, a transcription factor at the interface of
crucial cellular processes, plays a role downstream of serotonin in HCC cells.
Results: The cell viability and expression of FOXO3a was assessed in three HCC cell lines (Huh7, HepG2 and Hep3B)
during serum deprivation in the presence or absence of serotonin. Serum free media significantly inhibited HCC
proliferation and led to reduced expression and nuclear accumulation of FOXO3a. Knockdown of FOXO3a
enhanced the ability of serum deprivation to inhibit HCC cells proliferation. And overexpression of non-
phosphorylated FOXO3a in HCC cells reversed serum-deprivation-induced growth inhibition. Serotonin reversed the
serum-deprivation-induced inhibition of cell proliferation and upregulated FOXO3a in Huh7 cells; however,
serotonin had no effect on the proliferation of serum-deprived HepG2 or Hep3B cells. In addition to proliferation,
serotonin also induced phosphorylation of AKT and FOXO3a in serum-deprived Huh7 cells but not in HepG2 and
Hep3B cells. However, the phosphorylation of FOXO3a induced by serotonin did not export FOXO3a from nucleus
to cytoplasm in serum-deprived Huh7 cells. Consequently, we demonstrated that serotonin promoted the
proliferation of Huh7 cells by increasing the expression of FOXO3a. We also provide preliminary evidence that
different expression levels of the 5-HT2B receptor (5-HT2BR) may contribute to the distinct effects of serotonin in
different serum-deprived HCC cells.
Conclusions: This study demonstrates that FOXO3a functions as a growth factor in serum-deprived HCC cells and
serotonin promotes the proliferation of serum-deprived HCC cells via upregulation of FOXO3a, in the presence of
sufficient levels of the serotonin receptor 5-HT2BR. Drugs targeting the serotonin-5-HT2BR-FOXO3a pathway may
provide a novel target for anticancer therapy.
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Liver cancer remains the fifth most common malignancy
in men and the eighth most common malignancy in
women worldwide. The number of new cases of liver
cancer is still increasing every year, and the disease has a
poor prognosis and high rate of recurrence [1]. Many
cytokines contribute to the processes of initiation and* Correspondence: liangtingbo@zju.edu.cn
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reproduction in any medium, provided the ordevelopment in hepatocellular carcinoma, such as
interleukin-2 (IL-2), transforming growth factor ß (TGF-ß),
vascular endothelial growth factor (VEGF) and insulin
growth factor-1 (IGF-1).
Serotonin, also known as 5-hydroxytryptamine (5-HT),
is a neurotransmitter and vasoactive substance [2,3]. Apart
from its important roles in the central nervous system
(CNS), many studies have revealed that serotonin exerts
various extra-neuronal physiological and pathophysio-
logical functions. Peripheral serotonin is mostly stored intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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anti-apoptoticeffects in different tissues via binding to its
receptors [2,4-6]. Amongst the numerous 5-HT receptor
families, the 5-HT2B receptor (5-HT2BR) is necessary for
cell viability and proliferation [7]. 5-HT2BR is expressed at
low levels in discrete regions of the CNS; however, it is
expressed at high levels in the hepato-gastrointestinal (GI)
tract, including the liver [8]. This expression pattern
differs from the other type 5-HT2 receptors, which are
expressed at relatively high levels in the CNS [9]. The
physiological function of 5-HT2BR is still unclear, and
there are few studies of its downstream targets [4,10];
however, 5-HT2BR can initiate liver regeneration and
mediate hepatocyte fibrosis [11], which contributes to the
genesis of hepatocellular carcinoma.
FOXO3a is a member of class O of the fork head box
family of transcription factors which includes FKHR/
FOXO1, FKHRL1/FOXO3, AFX/FOXO4 and FOXO6
[12,13]. FOXO3a is homologous to the Caenorhabditis
elegans transcription factor Dauer Formation Influencing
Genes-16(DAF-16), which regulates lifespan by acting as
downstream of the C. elegans insulin receptor DAF-2
[13-16]. FOXO3a plays important roles in metabolism,
cellular proliferation, stress tolerance and also possibly
regulates the lifespan of mammalian cells [17-20]. Previ-
ous studies have shown that FOXO3a acts as a tumor
suppressor by inducing apoptosis [18,21]; and recent
researches have provided evidence that FOXO3a has mul-
tiple functions, especially with regards to aging and stress
resistance [19,20,22,23].These studies have suggested that
FOXO3a may exert opposing effects and orchestrate dif-
ferent responses, based on the extracellular stimuli or the
specific cell type [12,24-26]. As FOXO3a may mediate dif-
ferent cellular functions, we were interested to investigate
the role of FOXO3a in hepatocellular carcinoma, due to
the scarce research in this field.
As a common type of cellular stress, serum depriva-
tion can induce G0 phase cell cycle arrest and reduce
the proliferation of most cell types [27-29]. However,
serotonin can reverse the inhibition of proliferation in
serum-deprived HCC cells, which exhibit significant
growth inhibition in the absence of serotonin and even-
tually undergo complete necrotic death [30]. Recently,
accumulating evidence has revealed that FOXO3a can
ensure metabolic stability under stress conditions in
various cell types [17]. Loss of FOXO3a can enhance the
sensitivity of cells to stress, such as serum deprivation
[23,24]; however, there are few reports on the function
of FOXO3a in serum-deprived HCC cells. Therefore it
was of interest to investigate the expression pattern of
FOXO3a in response to serum deprivation in HCC cells.
We clarified the role of FOXO3a in serum-deprived
HCC cells treated with serotonin, and investigated
whether FOXO3a functions as a downstream target ofserotonin to modulate the proliferation of serum-deprived
HCC cells.
Materials and methods
Cell lines and cell culture
The human hepatocarcinoma cell lines (Huh7, Hep3B
and HepG2) were purchased from the Shanghai Institute
for Biological Science (Shanghai, China). HepG2 and
Huh7 cells were cultured in Dulbecco’s Minimal Essen-
tial Medium (DMEM; Gibco; Carlsbad, CA, USA) con-
taining 10% fetal bovine serum (FBS; Gibco), 100 U/mL
penicillin, and 100 mg/mL streptomycin. Hep3B cells
were cultured in Minimal Essential Medium (MEM;
Gibco) supplemented with 10% FBS and 1% penicillin/
streptomycin. The cells were maintained at 37°C in 5%
CO2 and 95% air.
Experimental conditions
HCC cells were harvested, re-plated and incubated over-
night to allow the cells to adhere. The cell cycle was
synchronized by incubating the cells in serum-free
medium for 24 h, then the media was replaced with
media containing drugs of different concentrations as
indicated. Most experiments contained three experimen-
tal groups: FBS group (media containing 10% FBS), SFM
group (serum free media containing 10% phosphate-
buffered saline) and the serum-free media plus serotonin
(SFM+5-HT) group. Cells were pretreated in the media
containing the 5-HT2B receptor antagonist SB204741
(SB204) for 30 minutes before addition of 5-HT. The
results from all assays were confirmed in at least three
independent experiments.
Drugs and antibodies
Serotonin-creatinine complex (5-HT) and the serotonin
2B receptor antagonist SB204741 were purchased from
Sigma-Aldrich (St. Louis, MO, USA). The total-FOXO3a
(t-FOXO3a), phospho-FOXO3a (Thr32; p-FOXO3a),
total-AKT (t-AKT), phospho-Akt (Ser473; p-AKT)
primary antibodies for Western blotting or immuno-
fluorescence staining were obtained from Cell Signaling
(Danvers, MA, USA), HRP-conjugated secondary anti-
body, mouse anti-GFP antibody and mouse anti-GAPDH
antibody were purchased from Kangchen Biotechnology
(Shanghai, China).
Assessment of cell viability and proliferation
Cell viability was measured using the cell count kit-8
(CCK-8; Dojindo; Kumamoto, Japan) following the
manufacturer’s protocol. HCC cells were plated into 96-
well plates at a density of 3000 cells/well in 100 μL
media. After starvation in serum-free medium for 24 h,
the media was removed and replaced with media
containing different concentrations of 5-HT. The cells
Liang et al. Molecular Cancer 2013, 12:14 Page 3 of 11
http://www.molecular-cancer.com/content/12/1/14were cultured for the indicated times. The relative viabil-
ity of HCC cells was expressed as the percentage of
CCK-8 value of synchronized cells without treatments.
Cell proliferation assay was performed using Click-iT
5-ethynyl-20-deoxyuridine (EdU) Imaging Kit (Invitrogen;
Carlsbad, CA, USA) following the manufacturer’s protocol.
After treatments described in cell viability assay, cells were
incubated with 10 μM EdU for 2h at 37°C. Then, cells were
fixed with 4% formaldehyde for 15 min at room
temperature and permeabilized with 0.5% Triton X-100 for
20 min at room temperature. After three washes with
phosphate-buffered saline (PBS), cells were incubated with
1X Click-iT reaction cocktails in dark for 30 min. HCC
cells nuclei stained by Hoechst 33342 were used to cell
count and visualized using an inverted fluorescence
\microscope (Olympus, Tokyo, Japan). For quantification of
HCC cells proliferative rate, five randomly selected views
from each sample image were used to calculate the relative
EdU-positive ratio.
Transfection of siRNAs
Cells were transfected with scrambled negative control
siRNA (NC-siRNA) or FOXO3a-siRNA (Santa Cruz Bio-
technology; Santa Cruz, CA, USA) using Lipofectamine
2000 (Invitrogen) for 6 h; all experiments were performed
in 24 h after transfection. The efficiency of the siRNA was
tested by measuring the relative FOXO3a protein expres-
sion levels by Western blotting. Transfected cells were re-
plated in 96-well plates (3000 cells/well), allowed to
adhere overnight and treated as previously described be-
fore the subsequent experiments.
Transfection of FOXO3a overexpression plasmid
The FOXO3a overexpression plasmid, pEGFP-c2-FOXO3a-
3A, in which the three AKT phosphorylation sites are
mutated, encoding constitutively active form of FOXO3a
was purchased from Addgene (Cambridge, MA, USA).
Cells were transfected with Negative control vector or
pEGFP-c2-FOXO3a-3A using Lipofectamine 2000 for
12h; fluorescent images were visualized using an inverted
fluorescence microscope at 24h after transfection. The
transfection efficiency was tested by measuring fusion
protein (EGFP-FOXO3a) expression by Western blot.
Immunofluorescence
HCC cells were seeded into 48-well plates at a density of
5000 cells/well and treated in conditioned media for the
indicated times. After treatments, cells were fixed with
4% formaldehyde before being permeabilized in ice-cold
PBS containing 0.1% Triton X-100 for 10 min, blocked
with 5% bovine serum albumin for 30 min at room
temperature, and incubated with anti-FOXO3a primary
antibody at 4°C overnight. After three washes with PBS, the
cells were incubated with secondary antibody conjugated toCy5 (Abcam; Cambridge, USA) at 4°C for 2 h followed by
incubation with 4',6-diamidino-2-phenylindole (DAPI;
Sigma) for 2 min at room temperature for nuclear coun-
terstain. The immunofluorescent images were observed
and captured using an inverted fluorescence microscope.
The quantification of subcellular localization of FOXO3a
was performed by calculating the percentage of FOXO3a
nuclear localization of 100 cells from five randomly
selected views of each sample image.
Flow cytometric analysis
Pretreated Huh7, HepG2 and Hep3B cells were
incubated in conditioned medium for 48 h, rinsed twice
with ice-cold PBS, fixed with 70% pre-chilled ethanol at
4°C overnight, centrifuged and washed twice with PBS.
Cell cycle analysis was performed by staining the DNA
with propidium iodide (PI; Dawen; Shanghai, China) and
flow cytometry. Quantitative cell cycle analysis was
performed using the ModFit software (Verity software
house; Topsham, ME, USA). Cell proliferation was
expressed as the proliferation index (PI), which is the
ratio of S+G2/M phase cells [31].
Quantitative real time PCR (qRT-PCR)
Total RNA was isolated and reverse transcribed from
Huh7, HepG2 and Hep3B cells in the FBS group, SFM
group or 5-HT group for 48H using TriZol Reagent
(Invitrogen) and Prime Script reagent RT Kit (Takara
Biotechnology Co.; Dalian, China) following the manufacturer’s
protocol. The primers for FOXO3a and 5-HT2BR were
designed and purchased from Takara: FOXO3a (forward,
5-TGCGTGCCCTACTTCAAGGATAA-3; reverse, 5-AC
AGGTTGTGCCGGATGGA-3), 5-HT2BR (forward, 5- CA
TGCATCTCTGTGCCATTTCA-3; reverse, 5-TGTTTGG
GTTGTCCACATCAGTC-3). qRT-PCR was performed on
the ABI 7900 Prism HT (Applied Biosystems Inc.;
Shanghai, China) followed by melting curve analysis.
FOXO3a and 5-HT2BR mRNA expression was normalized
to β-actin (forward, 5- TGGCACCCAGCACAATGAA-3; re-
verse, 5- CTAAGTCATAGTCCGCCTAGAAGCA-3); each
treatment was assayed in triplicate.
Western blotting
HCC cell lysates were washed twice in ice-cold PBS and
resuspended in cell lysis buffer (Cell Signaling) con-
taining protease inhibitors (Sigma). The protein concen-
tration was quantified using the BCA Protein assay kit
(Thermo Fisher Scientific Inc.; Rockford, IL, USA). The
protein lysates added with loading buffer were denaturated
by boiling, separated using 10% SDS-PAGE gels and then
transferred to polyvinyllidenediflouride (PVDF) mem-
branes (Millipore; Billerica, MA, USA), blocked with Tris-
buffered saline (TBS) and 0.1% Tween 20 (TBS/T)
containing 5% bovine serum albumin and then incubated
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anti-t-AKT, anti-p-AKT (Ser473), anti-GFP, anti-GAPDH
antibodies at 4°C overnight. The membranes were
washed three times with TBS/T, incubated with the
appropriate HRP-conjugated secondary antibody for 1
h at room temperature, washed. The protein bands
were developed by enhanced chemiluminescence (GE
Healthcare; Piscataway, NJ, USA) and visualized using
an autoradiography kit (Kodak; Rochester, NY, USA).
Band densities were estimated using Image Pro Plus
(Media Cybernetics, Inc.; Bethesda, MD, USA) and the
relative protein expression levels were normalized to
GAPDH.
Statistical analysis
All the experiments data were shown as the mean ± SD
values. Two-way analysis of variance (ANOVA) using
Bonferroni’s post-hoc tests or the Student’s t-test were
used to assess the significance of the different
treatments; statistical significance was defined as P<0.05.
Results
Serotonin exhibits a pro-proliferative effect in serum-
deprived Huh7 cells, but not in serum-deprived HepG2 or
Hep3B cells
To test if serotonin could promote the proliferation of
HCC cells, we measured the cell viability of Huh7,
HepG2 and Hep3B cells in the absence or presence of
10% fetal bovine serum in combination with serotonin.
After 48 h serum starvation, all cell lines exhibited much
lower viabilities compared to cells cultured in media
containing 10% FBS (Figure 1A, B, C; SFM vs. FBS,
***P<0.001, two-way ANOVA). However, in the presence
of serotonin, serum-deprived Huh7 cells exhibited a
similar growth trend to the FBS group, and after 48 hFigure 1 Serotonin promotes cell proliferation in serum-deprived Huh
media containing 10% fetal bovine serum (FBS), or serum free media (SFM
(C)Hep3B cells (compared with SFM, ***P < 0.001, NS denotes no significan
cells cultured in media containing 10% FBS with or without 5-HT (50 μM);serum deprivation, the cell viability of the serotonin
serum-deprived group was almost five-fold higher than
cells cultured in SFM alone (Figure 1A; SFM vs. SFM +
5-HT (50μM),*** P < 0.001, two-way ANOVA). However,
serotonin did not remarkably affect the proliferation of
HepG2 or Hep3B cells in SFM (Figure 1B, C; SFM vs.
SFM + 5-HT (50μM), NS denotes no significant differ-
ence, two way ANOVA).
To fully understand the pro-proliferative effect of sero-
tonin in Huh7 cells, we also investigated the effect of
serotonin in media containing 10% FBS. As shown in
Figure 1D, serotonin did not promote the proliferation
of Huh7 cells in the presence of 10% FBS (Figure 1D;
P>0.05, two way ANOVA).
FOXO3a is downregulated in serum-deprived cells
As the cell proliferation rates were notably reduced in
serum free conditions, we determined the effect of serum
deprivation on the expression of FOXO3a. We quantified
FOXO3a expression at the mRNA and protein levels in
Huh7, HepG2 and Hep3B cells cultured in serum free
medium for 48 h. Compared to the 10% FBS groups, the
expression of FOXO3a protein significantly decreased in
the serum-free groups (Figure 2A; FBS vs. SFM, *P < 0.05
for Huh7 and Hep3B, **P < 0.01 for HepG2, t-test;).
The real time qRT-PCR analysis displayed a similar trend
to the Western blotting results (Figure 2B; FBS vs. SFM,
*P < 0.05, t-test). These results indicated that FOXO3a
may be responsible, at least in part, for the reduced cell
proliferation rate induced by serum deprivation.
FOXO3a functions as a growth factor in serum-deprived
HCC cells
To explore the potential role of FOXO3a in serum-
deprived HCC cells, we artificially knocked down the7 cells. (A-C) Mean ± SD relative viability of HCC cells cultured in
) with or without serotonin (SFM + 5-HT); (A)Huh7 cells, (B)HepG2 cells,
t difference, two-way ANOVA). (D) Mean ± SD relative viability of Huh7
P>0.05, two way ANOVA.
Figure 2 Serum-deprivation reduces expression of FOXO3a in
HCC cells. (A, B) Western blot (A) and qRT-PCR analysis (B) of
FOXO3a expression in HCC cells cultured in media containing 10%
fetal bovine serum (FBS) or serum free media (SFM) for 48h; *P<0.05,
**P<0.01, t-test.
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The efficiency of interference was confirmed by Western
blotting (Figure 3A; WT vs. siRNA, **P < 0.01, t-test).
The cell count kit-8 assay demonstrated that cells
transfected with negative control siRNA initially
proliferated in the absence of 10% FBS; however,
FOXO3a-siRNA interference reduced the growth curve
and accelerated a decline in the viability of HCC cells in
the absence of 10% FBS (Figure 3B (a); SFM + FOXO3a-
siRNA vs. SFM + NC-siRNA, **P < 0.01 for Huh-7 and
Hep3B, two-way ANOVA; SFM + FOXO3a-siRNA vs.
SFM + NC-siRNA, **P<0.01 for HepG2, t-test). Interest-
ingly, we did not observe the same effect for FOXO3a-
siRNA in the presence of 10% FBS, as the growth curves
of control cells and cells transfected with FOXO3a-
siRNA were not significantly different in the presence of
10% FBS (Figure 3B (b); all P>0.05, two way ANOVA).To further confirm the role of FOXO3a in HCC cells,
we employed the overexpression pEGFP-c2-FOXO3a-3A
plasmid encoding constitutively active from of FOXO3a
(mutations in three AKT phosphorylation sites [32]) in
our research. The efficiency of transfection was confirmed
by Western blotting analysis (Figure 3E (b)). The CCK8
assay revealed that, compared to cells transfected with
control vector, pEGFP-c2-FOXO3a-3A transfection sig-
nificantly reversed the serum-deprivation-induced growth
inhibition in HCC cells (Figure 3F; compared with Nega-
tive control, ***P<0.001, two-way ANOVA).
A EdU incorporation assay was used to estimate HCC
cells proliferation. EdU is a nucleoside analog of thymi-
dine, which incorporates into DNA during the synthesis
of DNA [33]. We found that overexpressed active
FOXO3a significantly attenuated inhibition of new DNA
synthesis after 48h serum deprivation (Figure 3C, D;
**P<0.01, t-test).Taken together, these results indicated
FOXO3a plays a key role in maintaining proliferation of
serum-deprived HCC cells.
Serotonin upregulates FOXO3a in Huh7 cells, but not in
HepG2 or Hep3B cells
As serum deprivation led to reduced FOXO3a expres-
sion in HCC cells, we investigated whether FOXO3a was
involved in the molecular mechanism by which 5-HT
stimulates proliferation in serum-deprived Huh7 cells.
As predicted, serotonin upregulated FOXO3a protein
and mRNA expression in serum-deprived Huh7 cells
(Figure 4A, B; SFM vs. SFM + 5-HT,*P < 0.05, t-test), but
not in serum-deprived HepG2 or Hep3B cells. Addition-
ally, serotonin also increased FOXO3a protein expression
in Huh7 cells in the presence of FBS (Figure 4C; FBS vs.
FBS + 5-HT, *P < 0.05, t-test;).
Serotonin induces phosphorylation of AKT and FOXO3a
in serum-deprived Huh7 cells, but not in HepG2 or
Hep3B cells
To better identify the mechanism of regulation of
FOXO3a mediated by serotonin in HCC cells, immuno-
fluorescence staining was used to detect the subcellular
localization of FOXO3a in HCC cells after cultured in
media containing 10% FBS, serum free media with or
without serotonin for 48h. We found that FOXO3a
mainly located in cytoplasm in HCC cells in the pres-
ence of FBS, whereas FOXO3a predominately expressed
in nuclei when HCC cells were cultured in serum free
media with or without serotonin (Figure 4D, E, G, I). As
phosphorylation of FOXO3a is a critical mechanism to
regulate FOXO3a nuclear export, we also investigated
the phosphorylation of FOXO3a and AKT in HCC cells
cultured in serum free media in the presence or absence
of serotonin. Western bolt analysis results revealed that
serum deprivation caused decreased phosphorylation
Figure 3 Effect of FOXO3a on proliferation of serum-deprived HCC cells. (A) Western blot analysis of the efficiency of FOXO3a-siRNA (siRNA)
knockdown compared to control cells (WT); **P<0.01, t-test. (B) Mean ± SD relative viability of HCC cells cultured in serum free media (SFM) and
transfected with negative control siRNA (NC-siRNA) or FOXO3a-siRNA (a); Huh7 and Hep3B cells, SFM+NC-siRNA vs. SFM+FOXO3a-siRNA, **P <
0.01, two-way ANOVA; HepG2 cells, SFM+NC-siRNA vs. SFM+FOXO3a-siRNA, **P < 0.01, t-test. (B) Mean ± SD relative viability of HCC cells cultured
in media containing 10% fetal bovine serum (FBS) and transfected with FOXO3a-siRNA (b); all P>0.05, two way ANOVA. EdU staining patterns (C)
and the relative EdU-positvie cells ratio (D) of HCC cells transfected with pEGFP-c2-FOXO3a-3A plasmid or Negative control after 48h serum
deprivation; **P<0.01, t-test. (E) Fluorescent images of HCC cells transfected with pEGFP-c2-FOXO3a-3A plasmid (a) and Western blot analysis of
the efficiency of pEGFP-c2-FOXO3a-3A plasmid (plasmid) transfection compared to control cells (WT) (b). (F) Mean ± SD relative viability of HCC
cells cultured in serum free media (SFM) transfected with pEGFP-c2-FOXO3a-3A plasmid or Negative control; compared with negative control,
***P<0.001, two-way ANOVA.
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of FOXO3a in HCC cells in a time-dependently manner
(Figure 4F, H, J; phosphorylation ratio of AKT and
FOXO3a was not shown, see details in Additional file 1:
Figure S1). Serotonin markedly reversed the dephos-
phorylation of AKT induced by serum deprivation and
resulted in phosphorylation of FOXO3a in Huh7 cells,
but not in HepG2 and Hep3B cells (Figure 4F, H, J;phosphorylation ratio of AKT and FOXO3a was not
shown, see details in Additional file 1: Figure S1).
FOXO3a mediates serotonin-induced proliferation in
serum-deprived Huh7 cells
As serotonin significantly increased proliferation and
upregulated FOXO3a in serum-deprived Huh7 cells, next
we ascertained whether FOXO3a acted as a downstream
Figure 4 Effect of serotonin on the expression and phosphorylation of FOXO3a in serum-deprived HCC cells. (A, B) Western blot (A) and
qRT-PCR analysis (B) of FOXO3a expression in HCC cells cultured in serum free media (SFM) with or without serotonin (5-HT) for 48h; *P<0.05, t-
test. (C) Western blot analysis of FOXO3a expression in Huh7 cells cultured in media containing 10% fetal bovine serum (FBS) with or without 5-
HT (50 μM) for 48h; *P<0.05, t-test. (D) The subcellular localization of FOXO3a in Huh7 cells (a), HepG2 cells (b) and Hep3B cells ( c) after 48h
cultured in FBS, SFM or serum free media with serotonin (SFM+5-HT). Quantification of immunofluorescence staining patterns for FOXO3a in
Huh7 cells (E), HepG2 (G) cells and Hep3B cells (I); *P<0.05, t-test. ( F, H, J) Western blot analysis of total-AKT, phospho-Akt (Ser473; p-AKT), total-
FOXO3a and phospho-FOXO3a (Thr32; p-FOXO3a) in serum-deprived Huh7 cells (F), HepG2 cells (H) and Hep3B cells (J) cultured in the presence
or absence of serotonin (5-HT) for the indicated times.
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siRNA or FOXO3a-siRNA, and cultured in SFM in the
presence of 50 μM serotonin, and then cell proliferation
was measured and the cell cycle was analyzed by flow
cytometry.
FOXO3a-siRNA significantly reduced serum-deprived
Huh7 cell proliferation in the presence of serotonin,
compared with NC-siRNA-transfected cells (Figure 5A;
5-HT + FOXO3a-siRNA vs. 5-HT + NC-siRNA, **P < 0.01,
two-way ANOVA). We also determined Huh7 cells
proliferation by EdU incorporation assay. Consistent with
CCK8 assay, FOXO3a-siRNA significantly inhibited DNA
synthesis in Huh7 cells after 48h incubation in SFM in the
presence of serotonin (Figure 5B).As shown in Figure 5C, Huh7 cells incubated in SFM
for 48 h exhibited a low rate of proliferation; however
there was no significant difference in the S+G2/M
phase cell cycle ratio of control cells (39.25 ± 1.36%),
NC-siRNA transfected cells (38.62± 2.13%) and FOXO3a-
siRNA transfected cells (39.73 ± 1.51%) in the absence of
serotonin. In the presence of serotonin, the S+G2/M cycle
ratio significantly increased in control cells (51.23 ±
1.25%) and NC-siRNA transfected cells (50.10 ± 1.72%);
but not in FOXO3a-siRNA transfected cells (40.13 ±
0.96%). Serum-deprived cells transfected with FOXO3a-
siRNA in the presence of serotonin displayed a similar
rate of proliferation as control serum-deprived cells,
confirming that knockdown of FOXO3a inhibited the
Figure 5 Effect of serotonin and FOXO3a knockdown in serum-deprived Huh7 cells. (A) Mean ± SD relative cell viability of serum-deprived
Huh7 cells cultured in the presence of serotonin (5-HT) and transfected with Negative control siRNA (NC-siRNA) or FOXO3a-siRNA; 5-HT+NC-siRNA
vs. 5-HT+ FOXO3a-siRNA, **P < 0.01, two-way ANOVA. (B) EdU staining patterns of serum-deprived Huh7 cells transfected with Negative control
siRNA or FOXO3a-siRNA after 48h incubation with serotonin (5-HT).(C) Flow cytometry cell cycle analysis of serum-deprived Huh7 cells transfected
with NC-siRNA, FOXO3a-siRNA or cultured with 5-HT.
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deprived cells.Altered expression of the 5-HT2B receptor may regulate
the response of serum-deprived HCC cells to serotonin
Among the various types of serotonin receptor in human
tissues, the 5-HT2BR is expressed at high level in
hepatocytes. We investigated whether the regulation of
FOXO3a by 5-HT was regulated via 5-HT2BR. Firstly,
we determined the effect of the 5-HT2BR antagonist
SB204 on the viability of Huh7 cells cultured in SFM in
the presence of 5-HT. SB204 significantly reduced the
cell viability of serum-deprived Huh7 cells, compared to
cells cultured with 5-HT (50 μM) alone (Figure 6A; 5-
HT (50 μM) vs. 5-HT+SB204 (50 μM), ***P < 0.001,
two-way ANOVA), suggesting that serotonin regulates
cell proliferation via 5-HT2BR.As SB204 decreased the viability of serum-deprived
cells, we examined whether SB204 affected FOXO3a pro-
tein expression. The addition of SB204 (50 μM) to serum-
deprived Huh7 cells in the presence of 5-HT(50 μM)
reduced the protein expression levels of FOXO3a
(Figure 6B; 5-HT vs. SB204 + 5-HT, * P < 0.05, t-test).
In addition, we preliminarily investigated the mechan-
ism by which the three HCC cell lines responded differ-
ently to serotonin. As the 5-HT2B receptor played a role
in serum-deprived Huh7 cells, we investigated whether
the mRNA expression levels of this receptor varied in
different HCC cell lines. The basal expression levels of
5-HT2BR mRNA were significantly higher in Huh7 cells
than HepG2 and Hep3B cells (Figure 6C; Huh7 vs.
HepG2, *P<0.05, t-test; Huh7 vs. Hep3B; **P < 0.01,
t-test). This observation indicates that the higher expres-
sion levels of 5-HT2BR in serum-deprived Huh7 cells
can more effectively mediate 5-HT-induced proliferation,
Figure 6 Expression pattern of 5-HT2BR in HCC cells. (A) Mean ± SD relative cell viability of serum-deprived Huh7 cells cultured in the
presence or absence of serotonin (5-HT) and/or SB204; compared with 5-HT (50 μM), ***P < 0.001, two-way ANOVA. (B) Western blot analysis of
FOXO3a protein expression in serum-deprived Huh7 cells after incubation with SB204 (50 μM) and serotonin (50 μM) for 48h; *P<0.05, **P<0.01, t-
test. (C) qRT-PCR analysis of the basal expression levels of 5-HT2BR mRNA in HCC cells; *P<0.05, **P<0.01.
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receptor is expressed at lower levels.
Discussion
In addition to its function as a neurotransmitter in the
CNS, serotonin, especially peripheral serotonin, was re-
cently shown to promote the proliferation of many dif-
ferent cell types [2,5]. However, consensus on the
mechanism by which serotonin acts as a mitogen had
not yet been reached, and it was not known whether
serotonin acts via a receptor or receptor-independent
pathway, as the intracellular mechanisms underlying the
mitogenic effects of serotonin are poorly characterized.
In this study, we demonstrated that serotonin promoted
the proliferation of serum-deprived HCC cells via the
serotonin receptor 5-HT2BR and revealed that FOXO3a
was a key downstream effector of serotonin.
The FOXO transcription factor family is evolutionarily
conserved and plays important roles in development,
differentiation, proliferation, apoptosis, stress resistance
and metabolism [12,13]. Liang et al. reported that sero-
tonin targets and regulates the activation of DAF-16, the
C. elegans homologue of FOXO3a [34]. In mammals,
serotonin can also regulate the expression of FOXO3a in
the CNS [35]. However, the relationship between
serotonin and FOXO3a in HCC cells is poorly char-
acterized. Interestingly, we observed that FOXO3a was
downregulated in serum-deprived HCC cells, and that
knockdown of FOXO3a enhanced the sensitivity of HCC
cells to serum deprivation and overexpression of active
FOXO3a reversed the serum-deprivation-induced prolif-
erative inhibition, indicating that FOXO3a is required
for serum-deprived HCC cells to maintain normal
growth. Furthermore, our data suggested that serotonincould reverse the serum-deprivation-induced inhibition
of proliferation and G0/G1 phase cell cycle arrest, by in-
creasing the expression of FOXO3a.
Function of FOXO3a is intimately associated with its
post-translational modification (PTM), of which phos-
phorylation is the most important mechanism to
regulate FOXO3a subcellular localization and its tran-
scriptional activity [32]. In this study, we observed that
serum deprivation inactivated AKT and led to retention
of FOXO3a in nucleus. Serotonin had no effect on the
subcellular localization of FOXO3a in serum-deprived
HCC cells .However, serotonin increased the phosphor-
ylation of AKT and FOXO3a in serum-deprived Huh7
cells, but not in HepG2 or Hep3B cells. Interestingly, the
increased phosphorylation of FOXO3a induced by sero-
tonin did not parallel cytoplasmic translocation of
FOXO3a in Huh7 cells (Figure 4D (a)). The exact mech-
anism regulating nucleus/cytoplasm shuttling of
FOXO3a is still unknown, phosphorylation modification
is just one of many PTMs [36]. Moreover, a same stimuli
may induce reverse modification of FOXO protein [37].
The phosphorylation of FOXO3a induced by AMP-
activated protein kinase (AMPK) leads to accumulation
in nuclear localization of FOXO3a [38]. In this study, we
demonstrates that the promotion of serum-deprived
HCC cells proliferation exerted by serotonin is mainly
due to upregulation of FOXO3a in nucleus. However,
further experiments are still required to clarify the
precise mechanism of regulation of FOXO3a mediated
by serotonin in HCC cells.
These results are seemingly in contrast with previous
studies which reported that overexpression of FOXO3a
induced cell apoptosis and cell cycle arrest, such as
endothelial cells or follicular thyroid cancer cells, breast
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intersection between various cell signaling pathways;
however, the functions of FOXO3a and its target genes
are poorly characterized. Increasing numbers of studies
indicate that FOXO3a plays an important role in the ini-
tiation, progression and invasion of cancer [42,43]. Con-
stitutively nuclear FOXO3a localization is believed to be
associated with poor prognosis in breast cancer [44].
Storz et al. reported that FOXO3a promotes invasion in
cancer due to serum deprivation [43]. FOXO3a also acts
as a pro-survival factor in normal and cancer cells
adapting to hypoxic stress, by inhibiting hypoxia indu-
cible factor (HIF-1)-induced apoptosis [45]. Oh et al.
reported that FOXO3a protects T-cells from apoptosis
[46]. Lately, in agreement with our results, Li et al.
reported that FOXO3a promotes tumor cell survival in
serum deprivation [47].The underlying mechanisms
which explain the varying responses of cells to FOXO3a
have not yet been fully explored. The specific cell type,
growth environment or target genes may all contribute
to the different functions of FOXO3a. Although our
results extend the knowledge of the function of
FOXO3a, the existing knowledge does not yet form a
complete picture of the diverse mechanisms of action of
FOXO3a.
It is known that peripheral serotonin can mediate
proliferation of cells in the hepato-GI tract [2,5,6]; how-
ever, the mechanism of this mitogenic effect was
unknown. In this study, we proved that the serotonin
receptor 5-HT2BR mediates serotonin-induced pro-
liferation in serum-deprived Huh7 cells. Additionally, in-
hibition of 5-HT2BR in Huh7 cells using SB204, a unique
antagonist of 5-HT2BR, significantly decreased the ex-
pression of FOXO3a, demonstrating that FOXO3a was
the target of serotonin in Huh7 cells. Considering the ir-
regular distribution and expression pattern of 5-HT2BR
in human tissues, especially in tumor cells [3,4,9], it
was of interest to note that different expression levels
of 5-HT2BR could mediate a different response to serotonin
in Huh7 cells (which express high levels of 5-HT2BR)
compared to HepG2 and Hep3B cells (which express low
levels of 5-HT2BR).
In addition to the effect of serotonin in serum free
conditions, we also investigated the effect of serotonin in
the presence of 10% FBS. Serotonin could increase the
expression of FOXO3a in Huh7 cells cultured in 10%
FBS, but could not enhance the rate of proliferation.
Also, knockdown of FOXO3a in the presence of FBS
had no significant effect on the rate of proliferation.
These observations indicate that while FOXO3a is an in-
dispensable downstream target of serotonin in serum-
deprived cells, FOXO3a is not an essential component
for cell growth in the presence of the other conventional
growth-inducing polypeptides present in serum.Conclusion
In this study, we demonstrates that FOXO3a functions
as a growth factor in serum-deprived HCC cells and
serotonin promotes the proliferation of serum-deprived
HCC cells via upregulation of FOXO3a, in the presence
of sufficient levels of the serotonin receptor 5-HT2BR.
Knockdown of FOXO3a enhanced the sensitivity of
HCC cells to serum withdraw and inhibited cell growth.
Targeting of the serotonin-5-HT2BR-FOXO3a pathway
may be beneficial for liver cancer therapy.
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